NEWSLETTERS DIRECTED APNEA PATIENTS

Brand	Owner (click to sort)	Address	Description
DAYBREAK	RESPIRONICS, INC.	1010 Murry Ridge Lane Murrysville PA 156688525	newsletters directed to apnea patients concerning treatment and providing information relating to apnea;DAY BREAK;
DAYBREAK	RESPIRONICS, INC.	1010 Murry Ridge Lane Murrysville PA 156688525	newsletters directed to apnea patients concerning treatment and providing information relating to apnea;DAY BREAK;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

An implantable cardiac device is programmed to differentiate between central sleep apnea and obstructive sleep apnea. The implantable cardiac device utilizes a respiration-related parameter (e.g., respiration rate, tidal volume, and minute ventilation) to determine whether the patient is experiencing an episode of sleep apnea. When sleep apnea is detected, the implantable cardiac device examines the intracardiac electrogram (IEGM) to classify the apnea as either central sleep apnea or obstructive sleep apnea. The cardiac device may be further configured to administer different therapies depending upon the classification of sleep apnea.